FDA To Facilitate 4-AP Compassionate Use INDs For MS, Axelrad Says

FDA will ensure that multiple sclerosis patients taking 4-aminopyridine will continue to have the unapproved drug available through compassionate use INDs, Associate Director-Policy Jane Axelrad told the Pharmacy Compounding Advisory Committee July 14.